Document is current
Any future updates will be listed below
-
Authors
Gangadi, Μaria https://orcid.org/0000-0001-7968-4895
Kalpourtzi, Natasa https://orcid.org/0000-0002-2828-3140
Gavana, Μagda https://orcid.org/0000-0001-5567-5548
Vantarakis, Αpostolos
Chlouverakis, Gregory https://orcid.org/0000-0002-2855-772X
Hadjichristodoulou, Christos https://orcid.org/0000-0003-3843-9118
Trypsianis, Gregory https://orcid.org/0000-0002-2544-1721
Voulgari, Paraskevi V. https://orcid.org/0000-0002-5193-2284
Alamanos, Yannis https://orcid.org/0000-0001-5822-5702
Karakosta, Argyro https://orcid.org/0000-0002-4264-2250
Touloumi, Giota
Karakatsani, Anna https://orcid.org/0000-0002-3275-2026
-
Funding
Funding for this research was provided by:
European and National resources grants
Hellenic Diabetes Association
European Social Fund (MIS 376659)
- License Information
-
More Information
Article History
Received: 10 July 2025
Accepted: 22 December 2025
First Online: 15 January 2026
Declarations
:
: The EMENO study received approval from the Ethics and Deontology Committee of the National and Kapodistrian University of Athens (Approval Date: 8 November 2012, Protocol Number: 1742) and the Hellenic Data Protection Authority (Approval Date: 7 December 2012, Protocol Number: GN/EX/1069-1/07-12-2012). A revised version of the informed consent form (ICF) was subsequently approved by the Ethics and Deontology Committee of the National and Kapodistrian University of Athens (Approval Date: 6 March 2013, Protocol Number: 6315). Each participant signed an informed consent agreement. In the rare case that participants were unable to provide a signed informed consent, their legal representatives were asked instead. The research was conducted in compliance with the Helsinki Declaration (https://wwww.wma.net/policies-post/wma-declaration-of-helsinki/).
: Not applicable.
: The authors declare no competing interests.
